Gerald D. Brennan, Jr., JD, Chairman Phrixus Pharmaceuticals, Inc.
A former CFO and vice president administrative & financial operations at Aastrom Biosciences, Ann Arbor, Brennan is also a member of the Illinois Bar and CPA in Illinois. He came to Aastrom from Great Lakes Chemical Corporation, where he served as director, new ventures. Prior to that time, Brennan was CFO and COO of Capcom Coin-Op, Inc., and vice president of distributor operations and administration for Tupperware North America, president of Tupperware Canada and general counsel of Tupperware Worldwide. He has also served as tax counsel, Premark and as a tax manager, Coopers & Lybrand.
Degrees: BSBA in accounting and business economics, Marquette University, JD, University of Illinois.
Bruce Markham, President & CEO, Chief Scientific Officer and Co-founder Phrixus Pharmaceuticals, Inc.
In addition to Phrixus responsibilities, Bruce Markham serves as mentor-in-residence in the Office of Technology Transfer at the University of Michigan and on the advisory board of Cytometix. Prior to Phrixus, he was a research fellow at Pfizer in the cardiovascular area, where he brought six compounds to the clinical candidate stage and was a member of the licensing team. He began his career as an associate professor of physiology at the Medical College of Wisconsin, as well as an established investigator at the American Heart Association, and trained in molecular genetics at the University of Arizona.
Degrees: B.A., Western Michigan University; Ph.D., Michigan State University.